EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The N‐terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism

Xue Wang, Chunyou Ning, Xingyi Cheng, Zhengzhong Wu, Dongbo Wu, Xuemei Ding, Cunxiang Ju, Zhihang Zhou, Lingfeng Wan, Wei Zhao iD, Peiliang Shi

Animal Models and Experimental Medicine · 2025

DOI: 10.1002/ame2.12506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Xue Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: GemPharmatech Chengdu Co., Ltd., Chengdu, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Lipid Metabolism, Phosphate-Binding Proteins, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Key Project of Jiangsu Provincial Administration of Traditional Chinese Medicine, Natural Science Foundation of Laboratory Medicine School in Chengdu Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The emerging incidence of pathogenic liver conditions is turning into a major concern for global health. Induction of pyroptosis in hepatocytes instigates cellular disintegration, which in turn liberates substantial quantities of pro‐inflammatory intracellular substances, thereby accelerating the advancement of liver fibrosis. Consequently, directing therapeutic efforts towards inhibiting pyroptosis could potentially serve as an innovative approach in managing inflammation related chronic hepatic disorders.

Methods

GSDMD‐NT ki/wt mice and Alb‐cre ki/wt mice were generated using CRISPR/Cas9 technology. After crossing the two strains together, we induced conditional cell death by doxycycline to construct a mouse model of liver fibrosis. We analyzed differentially expressed genes by RNA sequencing and explored their biological functions. The efficacy of obeticholic acid (OCA) in the treatment of liver fibrosis was assessed.

Results

Doxycycline‐treated GSDMD‐NT ki/wt × Alb‐cre ki/wt mice showed severe liver damage, vacuolation of hepatocytes, increased collagen fibers, and accumulation of lipid droplets. The expression of liver fibrosis related genes was greatly increased in the doxycycline‐treated mouse liver compared with untreated mouse liver. RNA‐sequencing showed that upregulated differentially expressed genes were involved in inflammatory responses, cell activation, and metabolic processes. Treatment with OCA alleviated the liver fibrosis, with reduced ALT and AST levels seen in the GSDMD‐NT ki/wt × Alb‐cre ki/wt mice.

Conclusions

We successfully constructed a novel mouse model for liver fibrosis. This GSDMD‐NT‐induced fibrosis may be mediated by abnormal lipid metabolism. Our results demonstrated that we successfully constructed a mouse model of liver fibrosis, and GSDMD‐NT induced fibrosis by mediating lipid metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisLipid MetabolismPhosphate-Binding ProteinsIntracellular Signaling Peptides and ProteinsAnimalsMiceDisease Models, AnimalHepatocytesMice, Inbred C57BLMalePyroptosisLiverGasdermins

Stichwörter der Autor:innen

GSDMD‐NTNASHlipid metabolismliver fibrosispyroptosis

Substanzen

Gsdmd protein, mousePhosphate-Binding ProteinsIntracellular Signaling Peptides and ProteinsGasdermins

Autor:innen und Institutionen

  • GemPharmatech Chengdu Co., Ltd., Chengdu, China.
  • Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
  • Gempharmatech Shanghai Co., Ltd., Shanghai, China.
  • Department of Gastroenterology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Fatty Liver Disease Center of Integrated Chinese and Western Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
  • School of Clinical Medicine and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.

ORCID-Profile: Wei Zhao

Förderung

  • National Natural Science Foundation of China
  • Key Project of Jiangsu Provincial Administration of Traditional Chinese Medicine
  • Natural Science Foundation of Laboratory Medicine School in Chengdu Medical College
  • Sichuan Province Science and Technology Program
  • Technology innovation group project of Foshan 2019
  • Chengdu Medical College

Zitieren

APA

Wang, X., Ning, C., Cheng, X., Wu, Z., Wu, D., Ding, X., Ju, C., Zhou, Z., Wan, L., Zhao, W., & Shi, P. (2025). The N‐terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12506

Vancouver

Wang X, Ning C, Cheng X, Wu Z, Wu D, Ding X, et al. The N‐terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.12506

BibTeX
@article{Wang2025,
  author = {Wang, Xue and Ning, Chunyou and Cheng, Xingyi and Wu, Zhengzhong and Wu, Dongbo and Ding, Xuemei and Ju, Cunxiang and Zhou, Zhihang and Wan, Lingfeng and Zhao, Wei and Shi, Peiliang},
  title = {The N‐terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism},
  journal = {Animal Models and Experimental Medicine},
  year = {2025},
  doi = {10.1002/ame2.12506}
}
Kostenlos starten →